These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 12324672

  • 21. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R, Andrews S, Pimazzoni M, Callejas S, Ziviani L, Squassante L, Daley-Yates PT.
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
    Nayak A, Lanier R, Weinstein S, Stampone P, Welch M.
    Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
    [Abstract] [Full Text] [Related]

  • 23. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
    Horiguchi T, Hayashi N, Ohira D, Torigoe H, Ito T, Hirose M, Sasaki Y, Shiga M, Miyazaki J, Kondo R, Tachikawa S.
    J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
    [Abstract] [Full Text] [Related]

  • 24. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
    Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
    [Abstract] [Full Text] [Related]

  • 25. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 26. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
    Tatsis G, Kotsifas K, Filaditaki V, Makrantoni G, Boulia S.
    J Int Med Res; 2007 Jul; 35(3):361-73. PubMed ID: 17593865
    [Abstract] [Full Text] [Related]

  • 28. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
    Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J.
    Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
    [Abstract] [Full Text] [Related]

  • 29. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
    Ohbayashi H, Adachi M, Ichinose M, Ohta K, Kokubu F, Sano Y, Tamura G, Tohda Y, Hirata K, Yasuba H.
    Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
    [Abstract] [Full Text] [Related]

  • 30. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.
    Nair A, Menzies D, Hopkinson P, McFarlane L, Lipworth BJ.
    Br J Clin Pharmacol; 2009 Feb; 67(2):191-8. PubMed ID: 19220273
    [Abstract] [Full Text] [Related]

  • 31. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL, Noonan MJ, Weinstein SF, Chervinsky P, Scott CA, Herje NE, Wu W, Crim C.
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [Abstract] [Full Text] [Related]

  • 32. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
    Juniper EF, Buist AS.
    Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
    [Abstract] [Full Text] [Related]

  • 33. Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children.
    Lyttle B, Gilles J, Panov M, Emeryk A, Wixon C.
    Can Respir J; 2003 Mar; 10(2):103-9. PubMed ID: 12687029
    [Abstract] [Full Text] [Related]

  • 34. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.
    J Aerosol Med; 2002 Mar; 15(4):407-14. PubMed ID: 12581507
    [Abstract] [Full Text] [Related]

  • 35. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 36. Significant variability in response to inhaled corticosteroids for persistent asthma.
    Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA, Asthma Clinical Research Network of the National Heart Lung, and Blood Institute.
    J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
    [Abstract] [Full Text] [Related]

  • 37. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT, Milgrom H, Yoon YK, Levy AL, Matz P, Welch MJ, Cahn A, Collins DA, Kathman S, Mehta R, Su SF, Kunka RL.
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [Abstract] [Full Text] [Related]

  • 38. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG).
    Magnussen H.
    Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma.
    Robroeks CM, van de Kant KD, van Vliet D, Kester AD, Hendriks HJ, Damoiseaux JG, Wodzig WK, Rijkers GT, Dompeling E, Jöbsis Q.
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):601-7. PubMed ID: 18592826
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.